Literature DB >> 25049355

Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases.

Benoit Aubé1, Sébastien A Lévesque2, Alexandre Paré2, Émilie Chamma3, Hania Kébir4, Roser Gorina5, Marc-André Lécuyer4, Jorge I Alvarez4, Yves De Koninck6, Britta Engelhardt5, Alexandre Prat4, Daniel Côté3, Steve Lacroix7.   

Abstract

Disruption of the blood-brain and blood-spinal cord barriers (BBB and BSCB, respectively) and immune cell infiltration are early pathophysiological hallmarks of multiple sclerosis (MS), its animal model experimental autoimmune encephalomyelitis (EAE), and neuromyelitis optica (NMO). However, their contribution to disease initiation and development remains unclear. In this study, we induced EAE in lys-eGFP-ki mice and performed single, nonterminal intravital imaging to investigate BSCB permeability simultaneously with the kinetics of GFP(+) myeloid cell infiltration. We observed a loss in BSCB integrity within a day of disease onset, which paralleled the infiltration of GFP(+) cells into the CNS and lasted for ∼4 d. Neutrophils accounted for a significant proportion of the circulating and CNS-infiltrating myeloid cells during the preclinical phase of EAE, and their depletion delayed the onset and reduced the severity of EAE while maintaining BSCB integrity. We also show that neutrophils collected from the blood or bone marrow of EAE mice transmigrate more efficiently than do neutrophils of naive animals in a BBB cell culture model. Moreover, using intravital videomicroscopy, we demonstrate that the IL-1R type 1 governs the firm adhesion of neutrophils to the inflamed spinal cord vasculature. Finally, immunostaining of postmortem CNS material obtained from an acutely ill multiple sclerosis patient and two neuromyelitis optica patients revealed instances of infiltrated neutrophils associated with regions of BBB or BSCB leakage. Taken together, our data provide evidence that neutrophils are involved in the initial events that take place during EAE and that they are intimately linked with the status of the BBB/BSCB.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 25049355     DOI: 10.4049/jimmunol.1400401

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  86 in total

1.  Deficiency of Socs3 leads to brain-targeted EAE via enhanced neutrophil activation and ROS production.

Authors:  Zhaoqi Yan; Wei Yang; Luke Parkitny; Sara A Gibson; Kevin S Lee; Forrest Collins; Jessy S Deshane; Wayne Cheng; Amy S Weinmann; Hairong Wei; Hongwei Qin; Etty N Benveniste
Journal:  JCI Insight       Date:  2019-04-02

2.  AKT2 maintains brain endothelial claudin-5 expression and selective activation of IR/AKT2/FOXO1-signaling reverses barrier dysfunction.

Authors:  Richard S Beard; Brian A Hoettels; Jamie E Meegan; Travis S Wertz; Byeong J Cha; Xiaoyuan Yang; Julia T Oxford; Mack H Wu; Sarah Y Yuan
Journal:  J Cereb Blood Flow Metab       Date:  2018-12-21       Impact factor: 6.200

3.  Intricate Interplay between Innate Immune Cells and TRMP2 in a Mouse Model of Multiple Sclerosis.

Authors:  Céline Caravagna
Journal:  J Neurosci       Date:  2019-03-27       Impact factor: 6.167

Review 4.  The Diverse Biological Functions of Neutrophils, Beyond the Defense Against Infections.

Authors:  Fan Yang; Chang Feng; Xiaodong Zhang; Jun Lu; Yong Zhao
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

5.  Matrix Metalloproteinase-8 Inhibition Prevents Disruption of Blood-Spinal Cord Barrier and Attenuates Inflammation in Rat Model of Spinal Cord Injury.

Authors:  Hemant Kumar; Min-Jae Jo; Hyemin Choi; Manjunatha S Muttigi; Seil Shon; Byung-Joo Kim; Soo-Hong Lee; In-Bo Han
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

6.  Blood-brain barrier resealing in neuromyelitis optica occurs independently of astrocyte regeneration.

Authors:  Anne Winkler; Claudia Wrzos; Michael Haberl; Marie-Theres Weil; Ming Gao; Wiebke Möbius; Francesca Odoardi; Dietmar R Thal; Mayland Chang; Ghislain Opdenakker; Jeffrey L Bennett; Stefan Nessler; Christine Stadelmann
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

Review 7.  Myeloperoxidase: A new player in autoimmunity.

Authors:  Anna Strzepa; Kirkwood A Pritchard; Bonnie N Dittel
Journal:  Cell Immunol       Date:  2017-05-10       Impact factor: 4.868

8.  Gestational bisphenol-A exposure lowers the threshold for autoimmunity in a model of multiple sclerosis.

Authors:  James A Rogers; Manoj K Mishra; Jennifer Hahn; Catherine J Greene; Robin M Yates; Luanne M Metz; V Wee Yong
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

9.  IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis.

Authors:  Xin Zhang; Nazanin Kiapour; Sahil Kapoor; Joseph R Merrill; Yongjuan Xia; Woomi Ban; Stephanie M Cohen; Bentley R Midkiff; Valerie Jewells; Yen-Yu I Shih; Silva Markovic-Plese
Journal:  Clin Immunol       Date:  2018-08-24       Impact factor: 3.969

Review 10.  Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury.

Authors:  Hemant Kumar; Alexander E Ropper; Soo-Hong Lee; Inbo Han
Journal:  Mol Neurobiol       Date:  2016-05-18       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.